ACB Stock: Price, Forecast, Financials & AI Analysis

Loading...

Loading chart...

High

3.540

Open

3.450

VWAP

3.49

Vol

539.52K

Mkt Cap

199.05M

Low

3.430

Amount

1.88M

EV/EBITDA(TTM)

--

Total Shares

56.71M

EV

295.08M

EV/OCF(TTM)

--

P/S(TTM)

0.72

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company’s principal business lines are focused on the production, distribution and sale of cannabis and cannabis-derivative products in Canada and internationally. The Company’s segments include Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, IndiMed and CraftPlant. The Company also holds a 50.1% controlling interest in Bevo Farms Ltd., a supplier of propagated vegetables and ornamental plants in North America. Its subsidiaries include Aurora Cannabis Enterprises Inc., Aurora Deutschland GmbH, Whistler Medical Marijuana Corporation, and Indica Industries Pty Ltd., among others.

Show More

Events Timeline

(ET)

2026-03-09

08:50:00

Significant Increases in Indicative Borrow Rates for Liquid Options

2026-03-05 (ET)

2026-03-05

08:50:00

Klarna Group Borrow Rate Increases to 31.14%

2026-02-27 (ET)

2026-02-27

08:50:00

Latest Data Shows Gemini Space Station Borrow Rate Increases to 40.17%

2026-02-25 (ET)

2026-02-25

08:50:00

Largest Indicative Borrow Rate Increases Among Liquid Option Names

2026-02-19 (ET)

2026-02-19

08:50:00

Beyond Meat Borrow Rate Increases to 52.79%

2026-02-18 (ET)

2026-02-18

08:50:00

Innoviz Borrow Rate Increases to 3.84%

2026-02-12 (ET)

2026-02-12

08:50:00

Latest Data Shows Euro ETF Borrow Rate Rises to 8.63%

2026-02-11 (ET)

2026-02-11

07:20:00

Aurora Cannabis Expands Medical Portfolio in Australia and New Zealand

2026-02-04 (ET)

2026-02-04

07:30:00

Aurora Cannabis Files New Prospectus for $100M Common Shares Offering

News

Fool

Aurora Cannabis Faces Significant Challenges Ahead

NASDAQ.COM

02-26NASDAQ.COM

Aurora Cannabis Faces Significant Challenges Amid Regulatory Changes

Newsfilter

02-18Newsfilter

Aurora Cannabis to Discuss Growth Strategy at TD Cowen Conference

PRnewswire

02-17PRnewswire

Aurora Cannabis to Discuss Growth Strategy at Health Care Conference

PRnewswire

02-11PRnewswire

Aurora Expands Product Line in Australia and New Zealand

Yahoo Finance

02-08Yahoo Finance

Cannabis Sector Update: Aurora's Strategic Shift Amid Record Medical Sales

3 Analyst Rating

Wall Street analysts forecast ACB stock price to rise

3 Buy

0 Hold

0 Sell

Strong Buy

Current: 0.000

Low

6.28

Averages

6.77

High

7.39

Current: 0.000

Low

6.28

Averages

6.77

High

7.39

Canaccord

Buy

downgrade

$10 -> $9

AI Analysis

2026-02-05

Reason

Canaccord

Price Target

$10 -> $9

AI Analysis

2026-02-05

downgrade

Buy

Reason

Canaccord lowered the firm's price target on Aurora Cannabis to C$9 from C$10 and keeps a Buy rating on the shares.

Canaccord

Buy

initiated

$10

2026-01-27

Reason

Canaccord

Price Target

$10

2026-01-27

initiated

Buy

Reason

Canaccord initiated coverage of Aurora Cannabis with a Buy rating and C$10 price target. The medical-first operator is "the leading medical player" in Canada and "a foremost player" in the key international markets of Germany, Poland, Australia, and the UK, the analyst tells investors in a note starting coverage of the the Canadian cannabis group. A domestic pivot supported an expansion into the high-margin international markets, where gross margins are roughly 2.5-times higher, on average, than in Aurora's medically focused Canadian business, the analyst noted.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for ACB

Unlock Now

Valuation Metrics

The current forward P/E ratio for Aurora Cannabis Inc (ACB.O) is -19.87, compared to its 5-year average forward P/E of -57.66. For a more detailed relative valuation and DCF analysis to assess Aurora Cannabis Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

dotted line Image

N/A

5Y Average PE

-57.66

Current PE

-19.87

Overvalued PE

301.21

Undervalued PE

-416.53

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

dotted line Image

N/A

5Y Average EV/EBITDA

-7.44

Current EV/EBITDA

8.60

Overvalued EV/EBITDA

38.92

Undervalued EV/EBITDA

-53.80

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

dotted line Image

5Y Average PS

2.69

Current PS

0.88

Overvalued PS

5.18

Undervalued PS

0.19

Financials

AI Analysis

Annual

Quarterly

Related Community Screener

Should I Buy cannabis stocks?

Intellectia · 9 candidates

Market Cap: >= 50.00MThemes: The Cannabis IndustryList Exchange: XNYS, XNASMonthly Average Dollar Volume: >= 100,000

Ticker

Name

Market Cap$

Scotts Miracle-Gro Co

4.06B

Innovative Industrial Properties Inc

1.29B

Cronos Group Inc

1.01B

Tilray Brands Inc

874.97M

Canopy Growth Corp

440.50M

SNDL Inc

386.25M

what cannabis stocks would you buy?

Intellectia · 4 candidates

Market Cap: >= 200.00MPrice: >= $1.00Themes: The Cannabis IndustryQuarter Revenue Yoy Growth: >= 0.0%Monthly Average Dollar Volume: >= 300,000

Ticker

Name

Market Cap$

Cronos Group Inc

1.01B

Tilray Brands Inc

874.97M

SNDL Inc

386.25M

Aurora Cannabis Inc

204.15M

Intellectia · 8 candidates

Market Cap: >= 200.00MPrice: >= $1.00Themes: The Cannabis IndustryIs Optionable: TrueMonthly Average Dollar Volume: >= 200,000

Ticker

Name

Market Cap$

Scotts Miracle-Gro Co

4.06B

Innovative Industrial Properties Inc

1.29B

Cronos Group Inc

1.01B

Tilray Brands Inc

874.97M

Canopy Growth Corp

440.50M

SNDL Inc

386.25M

marijuana stocks

Intellectia · 8 candidates

Market Cap: >= 200.00MRegion: US, CanadaPrice: >= $1.00Themes: The Cannabis IndustryList Exchange: XNYS, XNAS, XASEIs Optionable: TrueMonthly Average Dollar Volume: >= 300,000

Ticker

Name

Market Cap$

Scotts Miracle-Gro Co

3.70B

Innovative Industrial Properties Inc

1.41B

Tilray Brands Inc

1.01B

Cronos Group Inc

999.35M

Canopy Growth Corp

460.70M

SNDL Inc

406.85M

Top cannabis stocks to buy

Intellectia · 9 candidates

Market Cap: >= 50.00MRevenue Ttm: >= 10.00MThemes: The Cannabis Industry

Ticker

Name

Market Cap$

Scotts Miracle-Gro Co

3.70B

Innovative Industrial Properties Inc

1.41B

Tilray Brands Inc

1.01B

Cronos Group Inc

999.35M

Canopy Growth Corp

460.70M

SNDL Inc

406.85M

Whales Holding ACB

Trading Trends

People Also Watch

Frequently Asked Questions

What is Aurora Cannabis Inc (ACB) stock price today?

The current price of ACB is 3.5 USD — it has decreased -0.28

What is Aurora Cannabis Inc (ACB)'s business?

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company’s principal business lines are focused on the production, distribution and sale of cannabis and cannabis-derivative products in Canada and internationally. The Company’s segments include Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, IndiMed and CraftPlant. The Company also holds a 50.1% controlling interest in Bevo Farms Ltd., a supplier of propagated vegetables and ornamental plants in North America. Its subsidiaries include Aurora Cannabis Enterprises Inc., Aurora Deutschland GmbH, Whistler Medical Marijuana Corporation, and Indica Industries Pty Ltd., among others.

What is the price predicton of ACB Stock?

Wall Street analysts forecast ACB stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ACB is6.77 USD with a low forecast of 6.28 USD and a high forecast of 7.39 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Aurora Cannabis Inc (ACB)'s revenue for the last quarter?

Aurora Cannabis Inc revenue for the last quarter amounts to 94.19M USD, increased 6.79

What is Aurora Cannabis Inc (ACB)'s earnings per share (EPS) for the last quarter?

Aurora Cannabis Inc. EPS for the last quarter amounts to 0.03 USD, decreased -94.23

How many employees does Aurora Cannabis Inc (ACB). have?

Aurora Cannabis Inc (ACB) has 1101 emplpoyees as of March 09 2026.

What is Aurora Cannabis Inc (ACB) market cap?

Today ACB has the market capitalization of 199.05M USD.